期刊文献+

YM155对人胃癌细胞株MKN28的作用及其机制研究 被引量:4

Effect and Mechanism of YM155 on Human Gastric Carcinoma Cell Line MKN28
下载PDF
导出
摘要 背景:研究发现生存素(survivin)在胃癌组织中高表达,YM155是survivin的特异性抑制剂。目的:探讨YM155对人胃癌细胞株MKN28的作用及其机制。方法:以不同浓度YM155作用于人胃癌细胞株MKN28。采用甲基噻唑基四唑(MTT)法检测细胞增殖抑制率;以原位末端标记(TUNEL法)检测细胞凋亡率;以逆转录聚合酶链反应(RTPCR)、蛋白质印迹法分别检测survivin mRNA和survivin、多聚ADP核糖聚合酶(PARP)、caspase-3蛋白表达。结果:YM155作用后,MKN28细胞增殖抑制,凋亡增加。随着YM155浓度升高,survivin mRNA和蛋白表达水平明显降低,并伴随PARP、caspase-3蛋白裂解。结论:YM155可抑制人胃癌细胞株MKN28增殖,并诱导其凋亡,此机制可能与抑制survivin表达,继而激活caspase凋亡信号通路有关。 It has been reported that survivin is over-expressed in human gastric cancer tissue. YM155 is the specific inhibitor of survivin. Aims: To investigate the effect and mechanism of YM155 on human gastric carcinoma cell line MKN28. Methods: Gastric carcinoma cell line MKN28 was treated with different concentrations of YM155. The cell proliferation inhibition rate was measured by methyl thiazolyl tetrazolium (MTT) assay. Cell apoptosis was determined by in situ end-labeling (TUNEL) method. The mRNA expression of survivin and protein expressions of survivin, poly (ADPribose) polymerase (PARP), and caspase-3 were determined by reverse transcription polymerase chain reaction (RT- PCR) and Western blotting, respectively. Results: The proliferation of MKN28 cells was inhibited and apoptosis was induced by YM155. Furthermore, the survivin mRNA and protein expressions were significantly decreased in MKN28 cells treated by YM155, accompanied by cleavage of PARP and caspase-3. Conclusions: YM155 can inhibit proliferation and induce apoptosis of human gastric carcinoma cell line MKN28, the mechanism may be related to inhibiting the expression of survivin, and resulting in activating the apoptotic signal pathway of caspase.
出处 《胃肠病学》 2013年第2期82-85,共4页 Chinese Journal of Gastroenterology
关键词 YM155 生存素 胃肿瘤 细胞增殖 细胞凋亡 YM155 Survivin Stomach Neoplasms Cell Proliferation Apoptosis
  • 相关文献

参考文献12

  • 1Tamm I, Wang Y, Sausville E, et al. lAP-family protein survivin inhibits caspase activity and apoptosis induced by F as (CD9S) , Bax, caspases , and anticancer drugs [ J J . Cancer Res, 1998,58 (23): 5315-5320.
  • 2Guha M, Altieri DC. Survivin as a global target of intrinsic tumor suppression networks [ J J. Cell Cycle, 2009, 8 (17): 2708-2710.
  • 3Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy [ JJ. Expert Opin Ther Targets, 2008, 12 (4) : 463476.
  • 4Sal! NK, Munshi A, Hobbs M, et al. Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells [ JJ. Int J Radiat Oncol Bioi Phys, 2006, 66 (3) : 852-859.
  • 5Choi KS, Lee TH, Jung MH. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells [ J J. Cancer Gene Ther, 2003, 10 (2) : 87-95.
  • 6Nakahara T, Kita A, Yamanaka K, et al. Broad spectrum and potent antitumor activities of YM155, a novel small?molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models [ J J. Cancer Sci, 2011, 102 (3) : 614-621.
  • 7Lewis KD, Samlowski W , Ward J, et al. A multi -center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage ill or N melanoma [ J]. Invest New Drugs, 2011 , 29 (1): 161- 166.
  • 8Giaccone G, Zatloukal P, Roubec J, et al. Multicenter phase II trial of YM155 , a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small?cell lung cancer [ JJ. J Clin Oncol, 2009, 27 (27) : 4481- 4486.
  • 9Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas [ JJ . Cancer Res, 1998,58 (9): 1808-1812.
  • 10Okada E, Murai Y, Matsui K, et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients [ J]. Cancer Lett, 2001, 163 (1): 109-116.

同被引文献44

  • 1丁艳,王宁,陈晓杰,徐冶.Survivin在甲状腺癌中的研究进展[J].吉林医药学院学报,2013,34(4):289-292. 被引量:2
  • 2马荣,陈曦海,张岂凡,朱镭,唐丽萍,王晶,成海燕,雷利娜.反义survivin核酸增强胃癌细胞对多西他赛敏感性及其逆转耐药机制的探讨[J].中华肿瘤杂志,2007,29(2):89-92. 被引量:11
  • 3Forouzanfar MH,Foreman KJ,Delossantos AM,et al. Breast andcervical cancer in 187 countries between 1980 and 2010 : a sys-tematic analysis[ J]. Lancet,2011,378(9801) : 1461-1484.
  • 4Rakha EA, El-Sayed ME, Green AR,et al. Prognostic markers intriple-negative breast cancer[ J]. Cancer,2007,109(1) :25-32.
  • 5Guha M, Altieri DC. Survivin as a global target of intrinsic tumorsuppression networks[ J]. Cell Cycle,2009 ,8( 17) :2708-2710.
  • 6Nakahara T, Kita A, Yamanaka K, et al. Broad spectrum and po-tent antitumor activities of YM155 , a novel small-molecjxle sur-vivin suppressant,in a wide variety of human cancer cell lines andxenograft models[ J]. Cancer Sci,2011,102(3) :614-621.
  • 7Waligorska-Stachura J, Jankowska A, Wasko R, et al. Survivin-prog*nostic tumor biomarker in human neoplasms-review[ J]. Ginekol Pol,2012,83(7) :537-540.
  • 8Hanahan D, Weinberg RA. Hallmarks of cancer: the next genera-tion[J]. Cell,2011,144(5) :646-674.
  • 9Iwasa T, Okamoto I,Suzuki M, et al. Radiosensitizing effect ofYM155, a novel small-molecfxle survivin suppressant, in non-small cell lung cancer cell lines [ J]. Clin Cancer Res,2008,14(20):6496-6504.
  • 10Kang R, Zeh HJ, Lotze MT, et al. The Beclin 1 networkregjxlates autophagy and apoptosis[ J]. Cell Death Differ,2011,18(4):571-580.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部